BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29030252)

  • 1. Sub-clonal analysis of the murine C1498 acute myeloid leukaemia cell line reveals genomic and immunogenic diversity.
    Driss V; Leprêtre F; Briche I; Mopin A; Villenet C; Figeac M; Quesnel B; Brinster C
    Immunol Lett; 2017 Dec; 192():27-34. PubMed ID: 29030252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.
    Distler E; Wölfel C; Köhler S; Nonn M; Kaus N; Schnürer E; Meyer RG; Wehler TC; Huber C; Wölfel T; Hartwig UF; Herr W
    Exp Hematol; 2008 Apr; 36(4):451-63. PubMed ID: 18261837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the anti-tumor efficacy of a GM-CSF-secreting tumor cell immunotherapy in preclinical models by cytosine arabinoside.
    Lin JM; Li B; Rimmer E; VanRoey M; Jooss K
    Exp Hematol; 2008 Mar; 36(3):319-28. PubMed ID: 18279719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells pulsed or fused with AML cellular antigen provide comparable in vivo antitumor protective responses.
    Weigel BJ; Panoskaltsis-Mortari A; Diers M; Garcia M; Lees C; Krieg AM; Chen W; Blazar BR
    Exp Hematol; 2006 Oct; 34(10):1403-12. PubMed ID: 16982333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single cell analysis of clonal architecture in acute myeloid leukaemia.
    Potter N; Miraki-Moud F; Ermini L; Titley I; Vijayaraghavan G; Papaemmanuil E; Campbell P; Gribben J; Taussig D; Greaves M
    Leukemia; 2019 May; 33(5):1113-1123. PubMed ID: 30568172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation.
    Stölzel F; Hackmann K; Kuithan F; Mohr B; Füssel M; Oelschlägel U; Thiede C; Röllig C; Platzbecker U; Schetelig J; Illmer T; Schaich M; Seliger B; Hartmann A; Baretton G; Zietz C; Ehninger G; Schrock E; Bornhäuser M
    Transplantation; 2012 Apr; 93(7):744-9. PubMed ID: 22314337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artesunate, a new antimalarial clinical drug, exhibits potent anti-AML activity by targeting the ROS/Bim and TFRC/Fe
    Liu Y; Li H; Luo Z; Yu Y; Yang J; Zhang M; Law BYK; Huang Z; Li W
    Br J Pharmacol; 2023 Mar; 180(6):701-720. PubMed ID: 36368726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine.
    Nahas MR; Stroopinsky D; Rosenblatt J; Cole L; Pyzer AR; Anastasiadou E; Sergeeva A; Ephraim A; Washington A; Orr S; McMasters M; Weinstock M; Jain S; Leaf RK; Ghiasuddin H; Rahimian M; Liegel J; Molldrem JJ; Slack F; Kufe D; Avigan D
    Br J Haematol; 2019 May; 185(4):679-690. PubMed ID: 30828801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-individualized CD8⁺ cytolytic T-cell therapy effectively combats minimal residual leukemia in immunodeficient mice.
    Distler E; Albrecht J; Brunk A; Khan S; Schnürer E; Frey M; Mottok A; Jordán-Garrote AL; Brede C; Beilhack A; Mades A; Tomsitz D; Theobald M; Herr W; Hartwig UF
    Int J Cancer; 2016 Mar; 138(5):1256-68. PubMed ID: 26376181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies reactive with human myeloid leukaemia cells.
    Ball ED; Fanger MW
    Clin Exp Immunol; 1982 Jun; 48(3):655-65. PubMed ID: 6956470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia.
    Hirsch P; Zhang Y; Tang R; Joulin V; Boutroux H; Pronier E; Moatti H; Flandrin P; Marzac C; Bories D; Fava F; Mokrani H; Betems A; Lorre F; Favier R; Féger F; Mohty M; Douay L; Legrand O; Bilhou-Nabera C; Louache F; Delhommeau F
    Nat Commun; 2016 Aug; 7():12475. PubMed ID: 27534895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of A Chimeric Antigen Receptor Targeting C-Type Lectin-Like Molecule-1 for Human Acute Myeloid Leukemia.
    Laborda E; Mazagova M; Shao S; Wang X; Quirino H; Woods AK; Hampton EN; Rodgers DT; Kim CH; Schultz PG; Young TS
    Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29077054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of minimal residual disease in acute myeloid leukemia.
    Gerhartz HH; Schmetzer H
    Leukemia; 1990 Jul; 4(7):508-16. PubMed ID: 1695705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
    J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes.
    Ehx G; Larouche JD; Durette C; Laverdure JP; Hesnard L; Vincent K; Hardy MP; Thériault C; Rulleau C; Lanoix J; Bonneil E; Feghaly A; Apavaloaei A; Noronha N; Laumont CM; Delisle JS; Vago L; Hébert J; Sauvageau G; Lemieux S; Thibault P; Perreault C
    Immunity; 2021 Apr; 54(4):737-752.e10. PubMed ID: 33740418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetically regulated clonal heritability of CTA expression profiles in human melanoma.
    Fratta E; Sigalotti L; Colizzi F; Covre A; Nicolay HJ; Danielli R; Fonsatti E; Altomonte M; Calabrò L; Coral S; Maio M
    J Cell Physiol; 2010 May; 223(2):352-8. PubMed ID: 20127705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal hierarchy of main molecular lesions in acute myeloid leukaemia.
    Herudkova Z; Culen M; Folta A; Jeziskova I; Cerna J; Loja T; Tom N; Smejkal J; Semerad L; Dvorakova D; Mayer J; Racil Z
    Br J Haematol; 2020 Aug; 190(4):562-572. PubMed ID: 31822038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous expression of different immunogenic antigens in acute myeloid leukemia.
    Greiner J; Ringhoffer M; Simikopinko O; Szmaragowska A; Huebsch S; Maurer U; Bergmann L; Schmitt M
    Exp Hematol; 2000 Dec; 28(12):1413-22. PubMed ID: 11146163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of acute myeloid leukaemia: development of a whole cell vaccine.
    Cheuk AT; Guinn BA
    Front Biosci; 2008 Jan; 13():2022-9. PubMed ID: 17981688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.